Osaic Holdings
EBS icon

Osaic Holdings’s Emergent Biosolutions EBS Stock Holding History

Osaic Holdings’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.5K Sell
11,504
-3,557
-24% -$36.8K ﹤0.01% 4722
2025
Q4 		$186K Sell
15,061
-317
-2% -$3.4K ﹤0.01% 4217
2025
Q3 		$135K Sell
15,378
-2,327
-13% -$18.1K ﹤0.01% 4536
2025
Q2 		$113K Sell
17,705
-3,583
-17% -$20.5K ﹤0.01% 4410
2025
Q1 		$103K Sell
21,288
-5,172
-20% -$42.8K ﹤0.01% 4138
2024
Q4 		$253K Buy
26,460
+10,188
+63% +$93.5K ﹤0.01% 3396
2024
Q3 		$136K Sell
16,272
-734
-4% -$6.67K ﹤0.01% 3974
2024
Q2 		$116K Buy
17,006
+7,066
+71% +$30.4K ﹤0.01% 4015
2024
Q1 		$25.1K Buy
9,940
+1,990
+25% +$4.49K ﹤0.01% 5212
2023
Q4 		$19.1K Sell
7,950
-916
-10% -$2.15K ﹤0.01% 5517
2023
Q3 		$30.1K Buy
8,866
+3,199
+56% +$17.7K ﹤0.01% 5320
2023
Q2 		$41.6K Buy
5,667
+3,301
+140% +$30.6K ﹤0.01% 5057
2023
Q1 		$24.8K Sell
2,366
-989
-29% -$12K ﹤0.01% 5444
2022
Q4 		$39.5K Sell
3,355
-810
-19% -$12.5K ﹤0.01% 5102
2022
Q3 		$87K Sell
4,165
-6,158
-60% -$171K ﹤0.01% 4487
2022
Q2 		$321K Sell
10,323
-635
-6% -$21.7K ﹤0.01% 3364
2022
Q1 		$445K Sell
10,958
-162
-1% -$7.14K ﹤0.01% 3329
2021
Q4 		$485K Sell
11,120
-90
-0.8% -$4.07K ﹤0.01% 3095
2021
Q3 		$563K Sell
11,210
-6,784
-38% -$411K ﹤0.01% 2911
2021
Q2 		$1.14M Buy
17,994
+6,488
+56% +$417K ﹤0.01% 2241
2021
Q1 		$1.06M Sell
11,506
-704
-6% -$72.1K ﹤0.01% 2178
2020
Q4 		$1.09M Sell
12,210
-4,977
-29% -$457K ﹤0.01% 1943
2020
Q3 		$1.77M Sell
17,187
-1,482
-8% -$160K 0.01% 1386
2020
Q2 		$1.48M Buy
18,669
+4,495
+32% +$335K 0.01% 1455
2020
Q1 		$820K Buy
+14,174
New +$817K ﹤0.01% 1684

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Osaic Holdings's EBS Position: Q1 2026 in Review

Osaic Holdings reduced its Emergent Biosolutions (EBS) stake by 24% in Q1 2026, selling an estimated $36.8K and leaving 11,504 shares worth $95.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4722.

Osaic Holdings first reported a position in EBS in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.77M in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Osaic Holdings held 11,504 shares of Emergent Biosolutions worth $95.5K as of Q1 2026.
  • Osaic Holdings sold 3,557 Emergent Biosolutions shares in Q1 2026, an estimated $36.8K.
  • Emergent Biosolutions made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4722 holding.
  • Osaic Holdings first reported a position in Emergent Biosolutions in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Emergent Biosolutions position peaked at $1.77M in Q3 2020.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.